Bath & Body Works (NYSE:BBWI – Get Free Report) updated its FY 2025 earnings guidance on Monday. The company provided EPS guidance of 3.250-3.600 for the period, compared to the consensus EPS estimate of 3.520. The company issued revenue guidance of $7.4 billion-$7.5 billion, compared to the consensus revenue estimate of $7.5 billion. Bath & Body Works also updated its Q1 2025 guidance to 0.490-0.490 EPS.
Bath & Body Works Stock Down 1.5%
Shares of NYSE BBWI traded down $0.50 during midday trading on Monday, hitting $33.26. The stock had a trading volume of 1,801,450 shares, compared to its average volume of 4,832,033. The stock has a 50 day simple moving average of $29.97 and a 200-day simple moving average of $34.00. The company has a market capitalization of $7.08 billion, a PE ratio of 8.12, a P/E/G ratio of 0.92 and a beta of 1.87. Bath & Body Works has a 1 year low of $24.96 and a 1 year high of $52.99.
Bath & Body Works (NYSE:BBWI – Get Free Report) last announced its quarterly earnings data on Thursday, February 27th. The company reported $2.09 earnings per share for the quarter, beating analysts’ consensus estimates of $2.04 by $0.05. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The company had revenue of $2.79 billion for the quarter, compared to analyst estimates of $2.78 billion. As a group, analysts expect that Bath & Body Works will post 3.3 earnings per share for the current fiscal year.
Bath & Body Works Dividend Announcement
Bath & Body Works announced that its board has approved a share buyback plan on Thursday, February 27th that allows the company to repurchase $500.00 million in shares. This repurchase authorization allows the company to buy up to 6.4% of its stock through open market purchases. Stock repurchase plans are often an indication that the company’s management believes its shares are undervalued.
Wall Street Analyst Weigh In
A number of equities research analysts have recently issued reports on BBWI shares. Raymond James dropped their price target on Bath & Body Works from $46.00 to $37.00 and set an “outperform” rating for the company in a research report on Thursday, April 17th. Telsey Advisory Group restated an “outperform” rating and issued a $43.00 target price on shares of Bath & Body Works in a report on Thursday, February 27th. Barclays cut their target price on Bath & Body Works from $38.00 to $31.00 and set an “equal weight” rating for the company in a research note on Monday, May 12th. Cowen reissued a “buy” rating on shares of Bath & Body Works in a research report on Thursday, February 27th. Finally, Piper Sandler set a $39.00 price objective on shares of Bath & Body Works and gave the company an “overweight” rating in a report on Thursday. Four investment analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $42.06.
View Our Latest Report on BBWI
Hedge Funds Weigh In On Bath & Body Works
A hedge fund recently raised its stake in Bath & Body Works stock. Royal Bank of Canada raised its position in Bath & Body Works, Inc. (NYSE:BBWI – Free Report) by 92.8% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 59,877 shares of the company’s stock after purchasing an additional 28,815 shares during the quarter. Royal Bank of Canada’s holdings in Bath & Body Works were worth $1,815,000 as of its most recent SEC filing. Institutional investors and hedge funds own 95.14% of the company’s stock.
Bath & Body Works Company Profile
Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
Featured Stories
- Five stocks we like better than Bath & Body Works
- Top Biotech Stocks: Exploring Innovation Opportunities
- Buffett’s Latest Portfolio Moves, and Another Secret Stock
- Using the MarketBeat Dividend Yield Calculator
- NVIDIA’s NVLink Fusion Ups the Ante for AI Infrastructure
- Why Invest in 5G? How to Invest in 5G Stocks
- Why Tesla’s 60% Surge Should Keep Going Into Summer
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.